22 April 2025 : Original article
Simultaneous Liver and Kidney Transplant in a Middle-Income Country: A Single-Center Experience
Laura Peña-Blanco ACDEF 1, Paula Santamaría-Rodriguez ABCDEF 1,2, Susana Beltrán-Villegas BCDEF 1, Juan Sebastián Montoya-Beltrán
ADEF 1, Nataly A. Ramírez ADEF 3, Carlos A. Benavides ABDEF 3, Félix Ramón Montes ACDEF 1*
DOI: 10.12659/AOT.947649
Ann Transplant 2025; 30:e947649
Table 1 Baseline characteristics.
| Adults (n=31) | Pediatric (n=10) | |
|---|---|---|
| Age (years) | 52 (47–60) | 6.5 (5–11.2) |
| Gender | ||
| Male | 18 (58%) | 5 (50%) |
| Female | 13 (42%) | 5 (50%) |
| BMI (kg/m) | 25.2±4.42 | 15.6±1.83 |
| Alcoholic cirrhosis | 12 (38.7%) | – |
| Congenital liver fibrosis | – | 5 (50%) |
| Polycystic liver disease | 6 (19.3%) | – |
| NASH cirrhosis | 4 (12.9%) | – |
| Others | 9 (29.1%) | 5 (50%) |
| Diabetic nephropathy | 15 (48.3%) | – |
| Polycystic kidney disease | 6 (19.3%) | 3 (30%) |
| IgA nephropathy | 3 (9.6%) | – |
| Nephronophthisis | – | 3 (30%) |
| Others | 7 (23%) | 4 (40%) |
| Hemoglobin | 11.3±2.32 | 9.2±2.4 |
| Platelets | 115,000 (80,200–219,000) | 200,000 (43,050–259,750) |
| Albumin | 2.9±1.01 | 3.37±0.8 |
| MELD/PELD score | 22±5.8 | 19.4±8.3 |
| 20 | 8 | |
| 11 | 2 | |
| Stage III a | 1 | – |
| Stage III b | 2 | – |
| Stage IV | 4 | 1 |
| Stage V | 4 | 1 |
| * Data are presented as n (%), median (interquartile range) or mean±standard deviation; ** CKD-EPI (2021) and the Schwartz formula were used to calculate GFR in adults and children, respectively. BMI – Body Mass Index; NASH – Non-Alcoholic Steatosis Hepatitis; GFR – Glomerular Filtration Rate. | ||